{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:05:33Z","timestamp":1777871133152,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00823-x","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:43:52Z","timestamp":1777095832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficiency of bone marrow-derived cells in the treatment of experimental autoimmune type 1 diabetes: immunomodulatory and anti-apoptotic properties"],"prefix":"10.1186","volume":"27","author":[{"given":"Mohamed","family":"Nassef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soha","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"6","key":"823_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/ph16060859","volume":"16","author":"OM Ahmed","year":"2023","unstructured":"Ahmed OM, Saleh AS, Ahmed EA, Ghoneim MM, Ebrahim HA, Abdelgawad MA, Abdel-Gabbar M. Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells and Hesperetin in the Treatment of Streptozotocin-Induced Type 1 Diabetes in Wistar Rats. Pharmaceuticals. 2023;16(6):859.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"823_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s42255-020-0173-1","volume":"2","author":"G Terrazzano","year":"2020","unstructured":"Terrazzano G, Bruzzaniti S, Rubino V, Santopaolo M, Palatucci AT, Giovazzino A, La Rocca C, de Candia P, Puca A, Perna F, Procaccini C, De Rosa V, Porcellini C, De Simone S, Fattorusso V, Porcellini A, Mozzillo E, Troncone R, Franzese A, Ludvigsson J, Matarese G, Ruggiero G, Galgani M. T1D progression is associated with the loss of CD3\u2009+\u2009CD56+ regulatory T cells that control CD8\u2009+\u2009T cell effector functions. Nat Metabolism. 2020;2(2):142\u201352.","journal-title":"Nat Metabolism"},{"issue":"1","key":"823_CR3","first-page":"1","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou A, Gudbj\u00f6rnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Lernmark \u00c5. Type 1 diabetes mellitus. Nat reviews Disease primers. 2017;3(1):1\u201317.","journal-title":"Nat reviews Disease primers"},{"issue":"2","key":"823_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/jcm8020249","volume":"8","author":"H Takahashi","year":"2019","unstructured":"Takahashi H, Sakata N, Yoshimatsu G, Hasegawa S, Kodama S. Regenerative and transplantation medicine: cellular therapy using adipose tissue-derived mesenchymal stromal cells for type 1 diabetes mellitus. J Clin Med. 2019;8(2):249.","journal-title":"J Clin Med"},{"issue":"3","key":"823_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.mpa.0000203961.16630.2f","volume":"32","author":"AN Balamurugan","year":"2006","unstructured":"Balamurugan AN, Bottino R, Giannoukakis N, Smetanka C. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes. Pancreas. 2006;32(3):231\u201343.","journal-title":"Pancreas"},{"key":"823_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1590\/1414-431x20154363","volume":"48","author":"AL M\u00e1rquez-Aguirre","year":"2015","unstructured":"M\u00e1rquez-Aguirre AL, Canales-Aguirre AA, Padilla-Camberos E, Esquivel-Solis H, D\u00edaz-Mart\u00ednez NE. Development of the endocrine pancreas and novel strategies for \u03b2-cell mass restoration and diabetes therapy. Braz J Med Biol Res. 2015;48:765\u201376.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"823_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2337\/dc13-1663","volume":"37","author":"F D\u2019Addio","year":"2014","unstructured":"D\u2019Addio F, Maffi P, Vezzulli P, Vergani A, Mello A, Bassi R, Nano R, Falautano M, Coppi E, Finzi G, D\u2019Angelo A, Fermo I, Pellegatta F, La Rosa S, Magnani G, Piemonti L, Falini A, Folli F, Secchi A, Fiorina P. Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes. Diabetes Care. 2014;37(1):267\u201376.","journal-title":"Diabetes Care"},{"issue":"3","key":"823_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2337\/diabetes.50.3.521","volume":"50","author":"H Zulewski","year":"2001","unstructured":"Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W, Muller B, Habener JF. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes. 2001;50(3):521\u201333.","journal-title":"Diabetes"},{"key":"823_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcell.2014.00009","volume":"2","author":"M Li","year":"2014","unstructured":"Li M, Ikehara S. Stem cell treatment for type 1 diabetes. Front cell Dev biology. 2014;2:9.","journal-title":"Front cell Dev biology"},{"issue":"4","key":"823_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1089\/dia.2018.0337","volume":"21","author":"LM Nally","year":"2019","unstructured":"Nally LM, Bondy N, Doiev J, Buckingham BA, Wilson DM. A feasibility study to detect neonatal hypoglycemia in infants of diabetic mothers using real-time continuous glucose monitoring. Diabetes Technol Ther. 2019;21(4):170\u20136.","journal-title":"Diabetes Technol Ther"},{"key":"823_CR11","doi-asserted-by":"publisher","first-page":"859638","DOI":"10.3389\/fendo.2022.859638","volume":"13","author":"XX Wan","year":"2022","unstructured":"Wan XX, Zhang DY, Khan MA, Zheng SY, Hu XM, Zhang Q, Xiong K. Stem cell transplantation in the treatment of type 1 diabetes mellitus: from insulin replacement to beta-cell replacement. Front Endocrinol. 2022;13:859638.","journal-title":"Front Endocrinol"},{"issue":"7","key":"823_CR12","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.4049\/jimmunol.2100949","volume":"208","author":"M Ben Nasr","year":"2022","unstructured":"Ben Nasr M, Robbins D, Parone P, Usuelli V, Tacke R, Seelam AJ, Driver E, Le T, Sabouri-Ghomi M, Guerrettaz L, Shoemaker D, Fiorina P. Pharmacologically Enhanced Regulatory Hematopoietic Stem Cells Revert Experimental Autoimmune Diabetes and Mitigate Other Autoimmune Disorders. J Immunol. 2022;208(7):1554\u201365.","journal-title":"J Immunol"},{"issue":"4","key":"823_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/19382014.2018.1480285","volume":"10","author":"EJ Arany","year":"2018","unstructured":"Arany EJ, Waseem M, Strutt BJ, Chamson-Reig A, Bernardo A, Eng E, Hill DJ. Direct comparison of the abilities of bone marrow mesenchymal versus hematopoietic stem cells to reverse hyperglycemia in diabetic NOD. SCID mice. Islets. 2018;10(4):137\u201350.","journal-title":"Islets"},{"issue":"7","key":"823_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/modpathol.2008.48","volume":"21","author":"JP Van Duong","year":"2008","unstructured":"Van Duong JP, Smadja DM, Bruneval P, Gaussem P, Dal-Cortivo L, Julia P, Fiessinger JN, Cavazzana-Calvo M, Aiach M, Emmerich J. Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Mod Pathol. 2008;21(7):837\u201346.","journal-title":"Mod Pathol"},{"issue":"7","key":"823_CR15","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/stem.87","volume":"27","author":"H Kim","year":"2009","unstructured":"Kim H, Park JS, Choi YJ, Kim MO, Huh YH, Kim SW, Han JW, Lee J, Kim S, Houge MA, Ii M, Yoon YS. Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells. 2009;27(7):1686\u201396.","journal-title":"Stem Cells"},{"issue":"3","key":"823_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0092-8674(01)00328-2","volume":"105","author":"DS Krause","year":"2001","unstructured":"Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Gardner R, Neutzel S, Sharkis SJ. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105(3):369\u201377.","journal-title":"Cell"},{"issue":"1","key":"823_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.14336\/AD.2019.0421","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Chen W, Feng B, Cao H. The clinical efficacy and safety of stem cell therapy for diabetes mellitus: a systematic review and meta-analysis. Aging disease. 2020;11(1):141\u201353.","journal-title":"Aging disease"},{"issue":"7","key":"823_CR18","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jcyt.2015.03.608","volume":"17","author":"UG Thakkar","year":"2015","unstructured":"Thakkar UG, Trivedi HL, Vanikar AV, Dave SD. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. Cytotherapy. 2015;17(7):940\u20137.","journal-title":"Cytotherapy"},{"issue":"4","key":"823_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/08916930903305641","volume":"43","author":"V Volarevic","year":"2010","unstructured":"Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity. 2010;43(4):255\u201363.","journal-title":"Autoimmunity"},{"issue":"1","key":"823_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/dc15-0171","volume":"39","author":"J Cai","year":"2016","unstructured":"Cai J, Wu Z, Xu X, Liao L, Chen J, Huang L, Wu W, Luo F, Wu C, Pugliese A, Pileggi A, Ricordi C, Tan J. Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion. Diabetes Care. 2016;39(1):149\u201357.","journal-title":"Diabetes Care"},{"issue":"2","key":"823_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db14-0656","volume":"64","author":"PO Carlsson","year":"2015","unstructured":"Carlsson PO, Schwarcz E, Korsgren O, Le Blanc K. Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2015;64(2):587\u201392.","journal-title":"Diabetes"},{"issue":"1","key":"823_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0511-8","volume":"8","author":"D Gerace","year":"2017","unstructured":"Gerace D, Martiniello-Wilks R, Nassif NT, Lal S, Steptoe R, Simpson AM. CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success? Stem Cell Res Ther. 2017;8(1):1\u201310.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"823_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11596-021-2323-4","volume":"41","author":"MT Chen","year":"2021","unstructured":"Chen MT, Zhao YT, Zhou LY, Li M, Zhang Q, Han Q, Xiao XH. Exosomes derived from human umbilical cord mesenchymal stem cells enhance insulin sensitivity in insulin-resistant human adipocytes. Curr Med Sci. 2021;41(1):87\u201393.","journal-title":"Curr Med Sci"},{"issue":"2","key":"823_CR24","doi-asserted-by":"publisher","first-page":"E259","DOI":"10.1152\/ajpendo.00393.2002","volume":"284","author":"A Lechner","year":"2003","unstructured":"Lechner A, Habener JF. Stem\/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am J Physiology-Endocrinology Metabolism. 2003;284(2):E259\u201366.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"5","key":"823_CR25","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1210\/en.2006-1351","volume":"148","author":"Y Hasegawa","year":"2007","unstructured":"Hasegawa Y, Ogihara T, Yamada T, Ishigaki Y, Imai J, Uno K, Katagiri H. Bone marrow (BM) transplantation promotes \u03b2-cell regeneration after acute injury through BM cell mobilization. Endocrinology. 2007;148(5):2006\u201315.","journal-title":"Endocrinology"},{"key":"823_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00262-013-1434-6","volume":"62","author":"JC Becker","year":"2013","unstructured":"Becker JC, Andersen MH, Schrama D, thor Straten P. Immune-suppressive properties of the tumor microenvironment. Cancer Immunol Immunother. 2013;62:1137\u201348.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"823_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","volume":"57","author":"K Le Blanc","year":"2003","unstructured":"Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57(1):11\u201320.","journal-title":"Scand J Immunol"},{"issue":"7","key":"823_CR28","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2337\/db08-0180","volume":"57","author":"R Abdi","year":"2008","unstructured":"Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 2008;57(7):1759\u201367.","journal-title":"Diabetes"},{"key":"823_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10875-008-9242-z","volume":"28","author":"JA Bluestone","year":"2008","unstructured":"Bluestone JA, Tang Q, Sedwick CE. T regulatory cells in autoimmune diabetes: past challenges, prospects. J Clin Immunol. 2008;28:677\u201384.","journal-title":"J Clin Immunol"},{"key":"823_CR30","first-page":"e938979","volume":"29","author":"AD Mesples","year":"2023","unstructured":"Mesples AD, Cox DC, Lundy HD, Antonio-Collie S, Diggis CW, Lakey JR. Monitoring of Autoantibodies Following Autologous Hematopoietic Stem Cell Transplantation in 6 Children with Recently Diagnosed Type 1 Diabetes Mellitus. Med Sci Monitor: Int Med J Experimental Clin Res. 2023;29:e938979\u20131.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"4","key":"823_CR31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/ard.2005.037879","volume":"65","author":"H Tsukamoto","year":"2006","unstructured":"Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K, Henzan H, Himeji D, Koyama T, Miyake K, Inoue Y, Nakashima H, Otsuka T, Tanaka Y, Nagasawa K, Harada M. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis. 2006;65(4):508\u201314.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"823_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12020-024-03929-7","volume":"86","author":"S Gomaa","year":"2024","unstructured":"Gomaa S, Nassef M, Hafez A. Potentials of bone marrow cells-derived from na\u00efve or diabetic mice in autoimmune type 1 diabetes: immunomodulatory, anti-inflammatory, anti-hyperglycemic, and antioxidative. Endocrine. 2024;86(3):959\u201379.","journal-title":"Endocrine"},{"issue":"1","key":"823_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","volume":"87","author":"JE Shaw","year":"2010","unstructured":"Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4\u201314.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"823_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1210\/er.2011-0008","volume":"32","author":"P Fiorina","year":"2011","unstructured":"Fiorina P, Voltarelli J, Zavazava N. Immunological applications of stem cells in type 1 diabetes. Endocr Rev. 2011;32(6):725\u201354.","journal-title":"Endocr Rev"},{"issue":"2","key":"823_CR35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.drudis.2019.11.016","volume":"25","author":"L Black","year":"2020","unstructured":"Black L, Zorina T. Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus. Drug Discovery Today. 2020;25(2):380\u201391.","journal-title":"Drug Discovery Today"},{"issue":"10","key":"823_CR36","first-page":"3499","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood J Am Soc Hematol. 2007;110(10):3499\u2013506.","journal-title":"Blood J Am Soc Hematol"},{"issue":"12","key":"823_CR37","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.yexcr.2006.03.019","volume":"312","author":"I Rasmusson","year":"2006","unstructured":"Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res. 2006;312(12):2169\u201379.","journal-title":"Exp Cell Res"},{"key":"823_CR38","doi-asserted-by":"crossref","unstructured":"Jayasinghe M, Prathiraja O, Perera PB, Jena R, Silva MS, Weerawarna PSH, Singhal M, Kayani AMA, Karnakoti S, Jain S. The role of mesenchymal stem cells in the treatment of type 1 diabetes. Cureus. 2022;14(7).","DOI":"10.7759\/cureus.27337"},{"issue":"5","key":"823_CR39","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","volume":"94","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circul Res. 2004;94(5):678\u201385.","journal-title":"Circul Res"},{"key":"823_CR40","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","volume":"10","author":"ARR Weiss","year":"2019","unstructured":"Weiss ARR, Dahlke MH. Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol. 2019;10:1191.","journal-title":"Front Immunol"},{"issue":"12","key":"823_CR41","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.2337\/db10-0542","volume":"59","author":"M Jurewicz","year":"2010","unstructured":"Jurewicz M, Yang S, Augello A, Godwin JG, Moore RF, Azzi J, Fiorina P, Atkinson M, Sayegh MH, Abdi R. Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes. 2010;59(12):3139\u201347.","journal-title":"Diabetes"},{"key":"823_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02173-4","volume":"12","author":"R Khatri","year":"2021","unstructured":"Khatri R, Petry SF, Linn T. Intrapancreatic MSC transplantation facilitates pancreatic islet regeneration. Stem Cell Res Ther. 2021;12:1\u201314.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"823_CR43","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.2337\/db12-0931","volume":"62","author":"DJ Kota","year":"2013","unstructured":"Kota DJ, Wiggins LL, Yoon N, Lee RH. TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity. Diabetes. 2013;62(6):2048\u201358.","journal-title":"Diabetes"},{"issue":"1","key":"823_CR44","doi-asserted-by":"publisher","first-page":"37894","DOI":"10.1038\/srep37894","volume":"6","author":"L Li","year":"2016","unstructured":"Li L, Hui H, Jia X, Zhang J, Liu Y, Xu Q, Zhu D. Infusion with human bone marrow-derived mesenchymal stem cells improves \u03b2-cell function in patients and non-obese mice with severe diabetes. Sci Rep. 2016;6(1):37894.","journal-title":"Sci Rep"},{"key":"823_CR45","doi-asserted-by":"publisher","first-page":"690623","DOI":"10.3389\/fimmu.2021.690623","volume":"12","author":"AF Refaie","year":"2021","unstructured":"Refaie AF, Elbassiouny BL, Kloc M, Sabek OM, Khater SM, Ismail AM, Ghoneim MA. From mesenchymal stromal\/stem cells to insulin-producing cells: immunological considerations. Front Immunol. 2021;12:690623.","journal-title":"Front Immunol"},{"issue":"5","key":"823_CR46","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/art.42081","volume":"74","author":"GS Gilkeson","year":"2022","unstructured":"Gilkeson GS. Safety and efficacy of mesenchymal stromal cells and other cellular therapeutics in rheumatic diseases in 2022: a review of what we know so far. Arthritis Rheumatol. 2022;74(5):752\u201365.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"823_CR47","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41467-022-28338-0","volume":"13","author":"K Piekarska","year":"2022","unstructured":"Piekarska K, Urban-W\u00f3jciuk Z, Kurkowiak M, Pelikant-Ma\u0142ecka I, Schumacher A, Sakowska J, Spodnik JH, Arcimowicz \u0141, Zieli\u0144ska H, Tymoniuk B, Renkielska A, Siebert J, S\u0142omi\u0144ska E, Trzonkowski P, Hupp T, Marek-Trzonkowska NM. Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity. Nat Commun. 2022;13(1):856.","journal-title":"Nat Commun"},{"issue":"1","key":"823_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4252\/wjsc.v14.i1.104","volume":"14","author":"YL Sun","year":"2022","unstructured":"Sun YL, Shang LR, Liu RH, Li XY, Zhang SH, Ren YK, Fu K, Cheng HB, Yahaya BH, Liu YL, Lin JT. Therapeutic effects of menstrual blood-derived endometrial stem cells on mouse models of streptozotocin-induced type 1 diabetes. World J Stem Cells. 2022;14(1):104\u201316.","journal-title":"World J Stem Cells"},{"issue":"8","key":"823_CR49","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/14712598.2020.1748596","volume":"20","author":"C Loretelli","year":"2020","unstructured":"Loretelli C, Assi E, Seelam AJ, Ben Nasr M, Fiorina P. Cell therapy for type 1 diabetes. Expert Opin Biol Ther. 2020;20(8):887\u201397.","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"823_CR50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s13287-022-03028-2","volume":"26","author":"Z Azizi","year":"2022","unstructured":"Azizi Z, Abbaszadeh R, Sahebnasagh R, Norouzy A, Motevaseli E, Maedler K. Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix? Stem Cell Res Ther. 2022;26(1):348.","journal-title":"Stem Cell Res Ther"},{"key":"823_CR51","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3389\/fimmu.2017.02001","volume":"8","author":"G Espinosa-Carrasco","year":"2018","unstructured":"Espinosa-Carrasco G, Le Saout C, Fontanaud P, Stratmann T, Mollard P, Schaeffer M, Hernandez J. CD4\u2009+\u2009T Helper Cells Play a Key Role in Maintaining Diabetogenic CD8\u2009+\u2009T Cell Function in the Pancreas. Front Immunol. 2018;8:2001.","journal-title":"Front Immunol"},{"issue":"17","key":"823_CR52","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.3390\/ijms231710023","volume":"23","author":"Y Huang","year":"2022","unstructured":"Huang Y, Wu Q, Tam PKH. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications. Int J Mol Sci. 2022;23(17):10023.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"823_CR53","first-page":"13","volume":"11","author":"M Sudarshan","year":"2025","unstructured":"Sudarshan M, Akansha L, Sharan S. Modeling Diabetes Mellitus Using Streptozotocin: Review approach for future diabetic research. IOSR J Biotechnol Biochem. 2025;11(3):13\u201321.","journal-title":"IOSR J Biotechnol Biochem"},{"issue":"4","key":"823_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/19382014.2018.1480285","volume":"10","author":"EJ Arany","year":"2018","unstructured":"Arany EJ, Waseem M, Strutt BJ, Chamson-Reig A, Bernardo A, Eng E, Hill DJ. Direct comparison of the abilities of bone marrow mesenchymal versus hematopoietic stem cells to reverse hyperglycemia in diabetic NOD.SCID mice. Islets. 2018;10(4):137\u201350.","journal-title":"Islets"},{"issue":"1","key":"823_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.14336\/AD.2019.0421","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Chen W, Feng B, Cao H. The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis. Aging disease. 2020;11(1):141\u201353.","journal-title":"Aging disease"},{"issue":"5","key":"823_CR56","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1210\/en.2006-1351","volume":"148","author":"Y Hasegawa","year":"2007","unstructured":"Hasegawa Y, Ogihara T, Yamada T, Ishigaki Y, Imai J, Uno K, Gao J, Kaneko K, Ishihara H, Sasano H, Nakauchi H, Oka Y, Katagiri H. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology. 2007;148(5):2006\u201315.","journal-title":"Endocrinology"},{"key":"823_CR57","first-page":"e938979","volume":"29","author":"AD Mesples","year":"2023","unstructured":"Mesples AD, Cox DCT, Lundy HD, Antonio-Collie S, Diggiss CW, Lakey JRT. Monitoring of Autoantibodies Following Autologous Hematopoietic Stem Cell Transplantation in 6 Children with Recently Diagnosed Type 1 Diabetes Mellitus. Med Sci monitor: Int Med J experimental Clin Res. 2023;29:e938979.","journal-title":"Med Sci monitor: Int Med J experimental Clin Res"},{"issue":"1","key":"823_CR58","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41392-024-02090-x","volume":"9","author":"R Abou Zaki","year":"2024","unstructured":"Abou Zaki R, El-Osta A. Advancing type 1 diabetes therapy: autologous islet transplant breakthrough. Signal Transduct Target therapy. 2024;9(1):366.","journal-title":"Signal Transduct Target therapy"},{"issue":"3","key":"823_CR59","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4093\/dmj.2011.35.3.199","volume":"35","author":"S Matsumoto","year":"2011","unstructured":"Matsumoto S. Clinical allogeneic and autologous islet cell transplantation: update. Diabetes metabolism J. 2011;35(3):199\u2013206.","journal-title":"Diabetes metabolism J"},{"key":"823_CR60","unstructured":"Champlin R. Selection of autologous or allogeneic transplantation. Holland-Frei Cancer Medicine. 2003:6."}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00823-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:02:27Z","timestamp":1777568547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00823-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00823-x","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures have been approved by the Institutional Animal Care and Use Committee (IACUC) at the Science Faculty, Tanta University, Egypt (approval ethical code: IACUC-SCI-TU-00487), ensuring proper care, accommodation, and methods to reduce suffering and distress among the animals. This research strictly complied with the ARRIVE guidelines throughout all the procedures to guarantee that the animals received optimal care during the study. All methods are reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}